SONEX RESEARCH INC
8-K, 1997-04-08
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PMC CAPITAL INC, DEF 14A, 1997-04-08
Next: MEDICAL RESOURCES INC /DE/, 10-K/A, 1997-04-08




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                Pursuant to Section 13 or 15(d) of the Securities
                              Exchange Act of 1934


        Date of Report (Date of earliest event reported): March 31, 1997


                              SONEX RESEARCH, INC.

               (Exact name of registrant as specified in Charter)


                           Maryland 0-14465 52-1188993

                  (State or other (Commision file (IRS employer  jurisdiction of
                   number) identification no.)
                                 incorporation)



                      23 Hudson Street, Annapolis, MD 21401

                    (Address of principal executive offices)


                                 (410) 266-5556

              (Registrant's telephone number, including area code)



                                       N/A

          (Former name or former address, if changed since last report)




<PAGE>



                             ITEM 5. - OTHER EVENTS


     On March 31, 1997, Sonex Research, Inc. (the "Company") completed a private
financing  in which it raised  $330,000  from a small  number  of the  Company's
existing  shareholders who qualified as accredited  investors.  Investments were
accepted in the minimum  amount of $15,000 in the form of a Unit  consisting  of
20,000 shares of the Company's $.01 par value common stock (the "Common  Stock")
and five-year  warrants to purchase an additional  10,000 shares of common stock
at $.75 per share.

     As previously  reported in a Form 8-K filing dated  February 28, 1997,  the
Company received an equity investment of $250,000 from Proactive Partners,  L.P.
and  certain  of  its  affiliates  (collectively  referred  to as  "Proactive").
Proactive are the largest  beneficial  owners of the  Company's  Common Stock by
virtue  of their  holdings  of  convertible  Preferred  Stock and  Common  Stock
purchase warrants.




                   ITEM 7. - FINANCIAL STATEMENTS AND EXHIBITS


     Attached hereto as Exhibit 1 is the pro-forma  balance sheet of the Company
as of December 31, 1996 assuming the two equity investments  described in Item 5
above had taken place on that date.


<PAGE>


                              SONEX RESEARCH, INC.
                           CURRENT REPORT ON FORM 8-K
                             PRO FORMA BALANCE SHEET
                                DECEMBER 31, 1996
                                   (Unaudited)


                                        As previously
                                           reported     Adjustments   Pro forma
                                           --------     -----------  ----------

     ASSETS

Current assets                           $   232,137    $ 580,000    $  812,137

Loans to employees - long-term                15,000                     15,000

Patents and technology                       239,308                    239,308

Property and equipment                        28,008                     28,008

                                         $   514,453    $ 580,000    $1,094,453
                                         -----------    ---------    ----------


LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities                      $   790,991                 $  770,991
                                         -----------                 ----------

Preferred stock - 1,550,001 shares            15,500                     15,500
Common stock - 16,214,020 shares as
     previously reported; 16,987,353
     shares pro forma                        162,140   $   7,733        169,873
Additional paid-in capital                19,165,535     572,267     19,737,802
Unrealized increase in value of
     marketable securities                    36,800                     36,800
Accumulated deficit                      (19,656,513)               (19,656,513)
                                         -----------                -----------

     Total stockholders' equity             (276,538)    580,000        303,462
                                         -----------    --------    -----------

                                         $   514,543   $ 580,000     $1,094,453
                                         -----------   ---------     ----------





     The pro forma adjustments reflect the cash investments aggregating $580,000
pursuant to which the Company issued 773,333 shares of Common Stock.


<PAGE>


                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.





April 8, 1997                                SONEX RESEARCH, INC.
                                             Registrant



                                                 /s/ George E. Ponticas
                                             -----------------------------
                                             George E. Ponticas
                                             Chief Financial Officer



<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission